推 stillcat:sent! 05/09 15:59
Title
Afatinib versus placebo for patients with advanced, metastatic
non-small-cell lung cancer after failure of erlotinib, gefitinib,
or both, and one or two lines of chemotherapy (LUX-Lung 1):
a phase 2b/3 randomised trial
Origin:
The Lancet Oncology, Volume 13, Issue 5, Pages 528 - 538, May 2012
Author:
Prof Vincent A Miller MD
拜求 paper 一篇
若有請寄到我的信箱 : skimylin@gmail.com
--
--
※ 發信站: 批踢踢實業坊(ptt.cc)
◆ From: 140.128.153.200